Triptigab Tablet SR
Marketer
Altygen Biopharm Pvt Ltd
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg)
Overview Triptigab Tablet SR
Triptigab SR tablets combine medications to alleviate neuropathic pain. They work by interrupting pain signal transmission to the brain, thus reducing pain perception. Triptigab SR should be taken orally, with or without food, ideally before sleep, at the same time daily for consistent blood levels. Follow your physician's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon remembering. Complete the entire course of treatment, even with symptom improvement. Never discontinue this medication abruptly without consulting your doctor. Common side effects may include constipation, urinary difficulty, weight gain, fatigue, and dry mouth. Dizziness and drowsiness are also possible; avoid driving or activities requiring concentration until its effects are known. Weight gain may occur; mitigate this through regular exercise and a balanced diet. Report any unusual mood or behavior changes, new or worsening depression, or suicidal thoughts to your doctor immediately. Prior to starting Triptigab SR, disclose any kidney or liver conditions, and list all other medications you are using, as interactions may affect efficacy or function. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Triptigab Tablet SR
Managing neuropathic pain
Major Benefits of Triptigab Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Triptigab Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of Triptigab Tablet SR:
- Dryness in mouth
- Increased heart rate
- Sleepiness
- Dizziness
- Tiredness
- Weight gain
- Blurred vision
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Uncoordinated body movements
- Increased appetite
- Increased libido
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Vomiting
- Nausea
- Erectile dysfunction
- Joint pain
- Constipation
- Difficulty in urination
How to use Triptigab Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Triptigab SR tablets can be consumed with or without food, though consistent timing is recommended.
How Triptigab Tablet SR works:
Triptigab SR tablets combine pregabalin and nortriptyline to alleviate neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain by modulating nerve cell calcium channel function. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thereby inhibiting pain signal transmission in the brain. This dual mechanism effectively manages pain originating from nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Triptigab SR tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Triptigab SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Triptigab tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Triptigab Tablet SR, due to potential side effects that can reduce alertness.
KidneyCAUTION
Patients with impaired kidney function should use Triptigab Tablet SR with care. Dosage modification of Triptigab Tablet SR might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Extended-release Triptigab tablets appear to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Triptigab Tablet SR :
Should you forget a Triptigab Tablet SR dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triptigab Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Nervous System |
FAQs on Triptigab Tablet SR
Triptigab SR tablets contain pregabalin and nortriptyline, working together to manage neuropathic pain. The medication soothes overly sensitive or injured nerves by affecting brain function, reducing the perception of pain.
Discontinuing Triptigab Tablet SR prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed dosage regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Taking Triptigab Tablet SR may increase appetite, potentially leading to weight gain. Weight management is simpler than weight loss. Maintain a balanced diet without enlarging portions. Avoid high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, choose fruits, vegetables, and low-calorie options instead of unhealthy snacks. Regular physical activity helps prevent weight gain. Combining healthy eating and exercise may preclude weight increase.
Triptigab SR tablets can cause drowsiness, potentially leading to unexpected sleep onset during routine tasks. This sleepiness may occur without prior warning signs. Therefore, refrain from driving, operating equipment, working at heights, or engaging in hazardous activities, especially when initiating treatment, until you assess the medication's impact on your alertness. Report any such sleep episodes to your physician.
Triptigab Tablet SR may impact sexual function in both males and females. Reported issues include reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if these effects arise, but do not discontinue Triptigab Tablet SR without medical advice.
Triptigab Tablet SR rarely causes severe adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, atypical mood or behavioral shifts (including agitation, anxiety, or elation), depressive symptoms, hallucinations, illogical thoughts, visual disturbances (blurred or double vision), involuntary eye movements, vision impairment, or indicators of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions necessitate prompt medical intervention.
Patients may experience initial improvements with Triptigab Tablet SR within two weeks, although complete therapeutic effects might not be evident for two to three months. In some cases, a longer timeframe may be necessary.
Should you miss a scheduled dose of Triptigab Tablet SR, and your next dose is imminent, omit the missed dose and continue with your regular schedule. If, however, sufficient time remains before your next dose, take the medication immediately upon remembering, then resume your usual dosage regimen. Avoid doubling up on doses to compensate for a missed one; this could heighten the risk of adverse reactions from an overdose. In cases of uncertainty, seek guidance from your physician on the appropriate course of action.
If this occurs, get in touch with your physician right away or go to the closest emergency room. Seek medical assistance promptly, regardless of whether you experience any symptoms. Overdose signs can manifest as sleepiness, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Exceeding the prescribed dosage won't necessarily enhance effectiveness; instead, it heightens the risk of severe adverse reactions and potential poisoning. Should your symptoms worsen despite adhering to the recommended dosage, seek immediate medical attention for reassessment.
Triptigab SR tablets can affect cognitive function and reflexes. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during Triptigab SR treatment due to the potential for intensified effects. Grapefruit and its juice may interact negatively with this medication, leading to adverse reactions. Limit sun exposure, including tanning beds, as Triptigab SR increases sun sensitivity. Protective clothing and sunscreen are recommended during daytime outdoor activities.
Regular check-ups with your physician are recommended following the commencement of Triptigab Tablet SR treatment. Consult your doctor immediately if your symptoms fail to improve with the prescribed Triptigab Tablet SR dosage, or if adverse effects interfere with your daily life.
Retain the tablets within their original packaging until ready for administration. Maintain storage in a cool, dry environment. Securing the medication from children's access is vital. Proper disposal of any leftover medication is essential to prevent accidental ingestion by children, pets, or others.
The extended-release Triptigab Tablet combines Pregabalin and Nortriptyline to manage neuropathic pain. Its mechanism involves calming overactive or injured nerves within the central nervous system, thus reducing pain perception.
Discontinuing Triptigab Tablet SR prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed dosage regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended before complete discontinuation.
Taking Triptigab SR tablets may increase appetite, potentially leading to weight gain. Managing weight gain is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging portions. Limit high-calorie foods like sugary drinks, fried foods, processed snacks, and sweets. Between meals, choose fruits, vegetables, and low-calorie options over junk food. Regular physical activity helps prevent weight gain. A healthy diet and consistent exercise may avoid weight increase altogether.
Triptigab SR tablets can cause drowsiness or sudden sleep onset during routine activities. This may occur without prior warning signs like drowsiness. Refrain from driving, operating equipment, working at heights, or engaging in hazardous tasks initially, until the medication's effects are understood. Report any such incidents to your physician.
Taking Triptigab Tablet SR may impact sexual function in both males and females. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and painful intercourse are also possible side effects. Report any such issues to your physician, but do not discontinue Triptigab Tablet SR without medical advice.
Triptigab Tablet SR rarely causes serious adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or elation), depressive symptoms, hallucinations, delusional thinking, visual disturbances (blurred or double vision), involuntary eye movements, vision impairment, or signs of recurrent infections (e.g., fever, rigors, pharyngitis, or oral ulcers). While infrequent, these side effects necessitate prompt medical intervention.
Patients may experience initial improvements with Triptigab Tablet SR within two weeks, though complete therapeutic effects typically manifest within two to three months. For some individuals, achieving maximal benefit may require a longer treatment duration.
Should you miss a scheduled dose of Triptigab Tablet SR, and your next dose is nearly due, omit the missed dose and proceed with your usual schedule. However, if sufficient time remains before your next dose, take the missed dose immediately and then resume your regular medication regimen. Never double the dose to compensate for a missed one, as this elevates the risk of adverse reactions from an overdose. In case of uncertainty, seek guidance from your physician regarding appropriate action.
If this occurs, promptly contact your physician or proceed directly to the nearest emergency room. This is crucial, regardless of the presence or absence of apparent symptoms. Immediate medical intervention may be necessary. Overdose symptoms can manifest as lethargy, debility, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Exceeding the prescribed dosage won't necessarily enhance efficacy; instead, it heightens the risk of severe adverse reactions and potential poisoning. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Triptigab Tablet SR can affect cognitive function and reflexes. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during Triptigab Tablet SR use as it may potentiate alcohol's effects, posing a risk. Grapefruit and its juice may interact adversely with this medication, potentially leading to undesirable side effects. Minimize sun exposure, including tanning beds, as Triptigab Tablet SR increases sun sensitivity. Protective clothing and sunscreen are recommended for daytime outdoor activities.
Regular check-ups with your physician are recommended following the initiation of Triptigab Tablet SR. Consult your doctor immediately if your symptoms persist despite taking the prescribed dose of Triptigab Tablet SR, or if you experience adverse effects that interfere with your daily life.
Retain the tablets in their original packaging until needed. Store in a cool, dry location, away from children's view and access. Proper disposal of leftover medication is crucial to prevent accidental ingestion by children, pets, or others.
Triptigab SR tablets combine pregabalin and nortriptyline to manage neuropathic pain. The medication soothes damaged or hyperactive nerves through central nervous system action, reducing pain perception.
Discontinuing Triptigab Tablet SR prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed dosage regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A phased reduction in dosage is usually necessary prior to complete discontinuation.
Extended-release Triptigab tablets may stimulate appetite, potentially leading to increased food consumption and weight gain. Weight management is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging portions. Limit high-calorie foods like sugary drinks, fried foods, chips, pastries, and confectionery. Between meals, opt for fruits, vegetables, and low-calorie snacks instead of junk food. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may prevent any weight increase.
Triptigab SR tablets can cause drowsiness or sudden sleep onset during routine tasks. These episodes may occur without prior warning signs like drowsiness. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until you assess the medication's effects. Report any such incidents to your physician.
Taking Triptigab Tablet SR may impact sexual function in both males and females. Reduced libido, erectile difficulties (inability to achieve or sustain an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and painful intercourse may also occur. Consult your physician if these side effects arise, but do not discontinue Triptigab Tablet SR without medical advice.
Triptigab SR tablets infrequently cause serious adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, lassitude, gait instability, impaired coordination or slowed reflexes, atypical mood or behavior shifts (including agitation, anxiety, or exhilaration), depressive symptoms, hallucinations, delusional thinking, visual disturbances (blurred or double vision), involuntary eye movements (nystagmus), visual impairment, or signs of recurrent infection (e.g., pyrexia, rigors, pharyngitis, or oral ulcers). While unusual, these reactions warrant prompt medical intervention.
Patients may experience initial improvements with Triptigab Tablet SR after a fortnight of therapy. Complete therapeutic effects, however, typically manifest within 2 to 3 months. In certain individuals, a longer timeframe may be necessary.
Should you miss a scheduled Triptigab Tablet SR dose, and your next dose is nearly due, omit the missed dose and continue with your usual schedule. If your next dose is not imminent, take the missed dose immediately upon remembering, then resume your regular medication regimen. Avoid doubling up on doses to compensate for a missed one; this elevates the risk of adverse reactions from exceeding the prescribed amount. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed directly to the nearest emergency room. Seek medical assistance regardless of the presence or absence of symptoms. Urgent care may be necessary. Overdose symptoms can manifest as lethargy, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve results; in fact, it could significantly raise your risk of adverse reactions and harmful effects. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Triptigab SR tablets can affect cognitive function and response times. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during Triptigab SR treatment, as it can potentiate the drug's effects, potentially leading to hazardous consequences. Grapefruit and grapefruit juice may interact negatively with this medication, resulting in adverse reactions. Minimize sun exposure and the use of tanning beds. Triptigab SR therapy increases sun sensitivity, therefore protective clothing and sunscreen are recommended during daytime outdoor activities.
Routine check-ups with your physician may be necessary following initiation of Triptigab Tablet SR therapy. Consult your doctor immediately if your symptoms fail to improve with the prescribed Triptigab Tablet SR dosage, or if you experience persistent adverse effects impacting your daily life.
Retain the tablets in their original packaging until needed. Store in a cool, dry location. Keep out of the reach and view of children. Dispose of any leftover medication appropriately to prevent accidental ingestion by children, pets, or others.
3,018 People bought this recently
Triptigab Tablet SR
203
MRP 247
17% off